71 related articles for article (PubMed ID: 1833201)
21. Increased division of alpha beta TCR+ and gamma delta TCR+ intestinal intraepithelial lymphocytes after oral administration of cholera toxin.
Penney I; Kilshaw PJ; MacDonald TT
Immunology; 1996 Sep; 89(1):54-8. PubMed ID: 8911140
[TBL] [Abstract][Full Text] [Related]
22. Generation of gamma interferon responses in murine Peyer's patches following oral immunization.
George A
Infect Immun; 1996 Nov; 64(11):4606-11. PubMed ID: 8890214
[TBL] [Abstract][Full Text] [Related]
23. T cell receptor V beta expression in human intestine: regional variation in postnatal intestine and biased usage in fetal gut.
Thomas R; Schürmann G; Lionetti P; Pender SL; MacDonald TT
Gut; 1996 Feb; 38(2):190-5. PubMed ID: 8801195
[TBL] [Abstract][Full Text] [Related]
24. Expression of major histocompatibility complex class II antigens on normal porcine intestinal endothelium.
Wilson AD; Haverson K; Southgate K; Bland PW; Stokes CR; Bailey M
Immunology; 1996 May; 88(1):98-103. PubMed ID: 8707357
[TBL] [Abstract][Full Text] [Related]
25. CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin.
Hörnquist E; Grdic D; Mak T; Lycke N
Immunology; 1996 Feb; 87(2):220-9. PubMed ID: 8698383
[TBL] [Abstract][Full Text] [Related]
26. The anatomy of T-cell activation and tolerance.
Mondino A; Khoruts A; Jenkins MK
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2245-52. PubMed ID: 8637857
[TBL] [Abstract][Full Text] [Related]
27. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.
Takahashi I; Kiyono H; Jackson RJ; Fujihashi K; Staats HF; Hamada S; Clements JD; Bost KL; McGhee JR
Infect Immun; 1996 Apr; 64(4):1290-8. PubMed ID: 8606092
[TBL] [Abstract][Full Text] [Related]
28. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization.
Daynes RA; Enioutina EY; Butler S; Mu HH; McGee ZA; Araneo B A
Infect Immun; 1996 Apr; 64(4):1100-9. PubMed ID: 8606065
[TBL] [Abstract][Full Text] [Related]
29. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.
Nashar TO; Webb HM; Eaglestone S; Williams NA; Hirst TR
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):226-30. PubMed ID: 8552610
[TBL] [Abstract][Full Text] [Related]
30. Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.
Bourguin I; Chardès T; Bout D
Infect Immun; 1993 May; 61(5):2082-8. PubMed ID: 8478097
[TBL] [Abstract][Full Text] [Related]
31. Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.
Chardès T; Velge-Roussel F; Mevelec P; Mevelec MN; Buzoni-Gatel D; Bout D
Immunology; 1993 Mar; 78(3):421-9. PubMed ID: 8478024
[TBL] [Abstract][Full Text] [Related]
32. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
Wu HY; Russell MW
Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
[TBL] [Abstract][Full Text] [Related]
33. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
34. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
Bowen JC; Nair SK; Reddy R; Rouse BT
Immunology; 1994 Mar; 81(3):338-42. PubMed ID: 8206507
[TBL] [Abstract][Full Text] [Related]
35. Oral tolerance.
Weiner HL
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10762-5. PubMed ID: 7971958
[No Abstract] [Full Text] [Related]
36. Distinct lymphokine production by CD4+ T cells isolated from mucosal and systemic lymphoid organs.
Tonkonogy SL; Swain SL
Immunology; 1993 Dec; 80(4):574-80. PubMed ID: 7905860
[TBL] [Abstract][Full Text] [Related]
37. Production of cytokines by lymphocytes from spleen, mesenteric lymph node and intestinal lamina propria of pigs.
Bailey M; Hall L; Bland PW; Stokes CR
Immunology; 1994 Aug; 82(4):577-83. PubMed ID: 7835920
[TBL] [Abstract][Full Text] [Related]
38. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.
Roberts M; Bacon A; Rappuoli R; Pizza M; Cropley I; Douce G; Dougan G; Marinaro M; McGhee J; Chatfield S
Infect Immun; 1995 Jun; 63(6):2100-8. PubMed ID: 7768587
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
Vajdy M; Lycke N
Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
[TBL] [Abstract][Full Text] [Related]
40. Primary antigen-specific T-cell proliferative responses following presentation of soluble protein antigen by cells from the murine small intestine.
Williams NA; Wilson AD; Bailey M; Bland PW; Stokes CR
Immunology; 1992 Apr; 75(4):608-13. PubMed ID: 1592436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
